Performance Evaluation of Machine Learning Algorithms for Dengue Disease Prediction

2019 ◽  
Vol 16 (12) ◽  
pp. 5105-5110
Author(s):  
S. Kannimuthu ◽  
K. S. Bhuvaneshwari ◽  
D. Bhanu ◽  
A. Vaishnavi ◽  
S. Ahalya

Dengue is a dangerous disease caused by female mosquitoes. Dengue fever (also called as breakbone fever) is a infection that can cause to a severe illness which is happened by four different viruses and spread by Aedes mosquitoes. It is the necessary to devise effective methodology for dengue disease prognosis. Machine learning is a sub-filed of artificial intelligence (AI) which offers systems the ability to learn and improve from experience without human intervention and being explicitly programmed. In this research work, the performance analysis of various prediction models is done for dengue disease prediction. It is observed that C4.5 algorithm outperforms well in terms of performance measures such as accuracy (89.33%), prediction (88.9%), recall (89.77%) and other measures.

2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Fathima Aliyar Vellameeran ◽  
Thomas Brindha

Abstract Objectives To make a clear literature review on state-of-the-art heart disease prediction models. Methods It reviews 61 research papers and states the significant analysis. Initially, the analysis addresses the contributions of each literature works and observes the simulation environment. Here, different types of machine learning algorithms deployed in each contribution. In addition, the utilized dataset for existing heart disease prediction models was observed. Results The performance measures computed in entire papers like prediction accuracy, prediction error, specificity, sensitivity, f-measure, etc., are learned. Further, the best performance is also checked to confirm the effectiveness of entire contributions. Conclusions The comprehensive research challenges and the gap are portrayed based on the development of intelligent methods concerning the unresolved challenges in heart disease prediction using data mining techniques.


2021 ◽  
Vol 9 (2) ◽  
pp. 554-564
Author(s):  
Golmei Shaheamlung, Harshpreet Kaur

In the 21st-century, the issue of liver disease has been increasing all over the world. As per the latest survey report, liver disease death toll has been rise approximately 2 million per year worldwide. The overall percentage of death by liver disease is 3.5% worldwide. Chronic Liver disease is also considered to be one of the deadly diseases, so early detection and treatment can recover the disease easily. Due to rapid advancement in Artificial intelligence (AI), like various machine learning algorithms SVM, K-mean clustering, KNN, Random forest, Logistic regression, etc., This will improve the life span of a patient suffering from Chronic Liver Disease (CLD) in early stages. The data can be obtained in a large volume due to the broad exploitation of bar codes for supreme marketable products, the mechanization of various business and government dealings, and the development in the data collection tools. This research work is based on liver disease prediction using machine learning algorithms. Liver disease prediction has various levels of steps involved, pre-processing, feature extraction, and classification. In this s research work, a hybrid classification method is proposed for liver disease prediction. And Datasets are collected from the Kaggle database of Indian liver patient records. The proposed model achieved an accuracy of 77.58%. The proposed technique is implemented in Python with the Spyder tool and results are analyzed in terms of accuracy, precision, and recall.  


2020 ◽  
Author(s):  
Yuan Zhao ◽  
Erica P Wood ◽  
Nicholas Mirin ◽  
Rajesh Vedanthan ◽  
Stephanie H Cook ◽  
...  

Background: Cardiovascular disease (CVD) is the number one cause of death worldwide, and CVD burden is increasing in low-resource settings and for lower socioeconomic groups worldwide. Machine learning (ML) algorithms are rapidly being developed and incorporated into clinical practice for CVD prediction and treatment decisions. Significant opportunities for reducing death and disability from cardiovascular disease worldwide lie with addressing the social determinants of cardiovascular outcomes. We sought to review how social determinants of health (SDoH) and variables along their causal pathway are being included in ML algorithms in order to develop best practices for development of future machine learning algorithms that include social determinants. Methods: We conducted a systematic review using five databases (PubMed, Embase, Web of Science, IEEE Xplore and ACM Digital Library). We identified English language articles published from inception to April 10, 2020, which reported on the use of machine learning for cardiovascular disease prediction, that incorporated SDoH and related variables. We included studies that used data from any source or study type. Studies were excluded if they did not include the use of any machine learning algorithm, were developed for non-humans, the outcomes were bio-markers, mediators, surgery or medication of CVD, rehabilitation or mental health outcomes after CVD or cost-effective analysis of CVD, the manuscript was non-English, or was a review or meta-analysis. We also excluded articles presented at conferences as abstracts and the full texts were not obtainable. The study was registered with PROSPERO (CRD42020175466). Findings: Of 2870 articles identified, 96 were eligible for inclusion. Most studies that compared ML and regression showed increased performance of ML, and most studies that compared performance with or without SDoH/related variables showed increased performance with them. The most frequently included SDoH variables were race/ethnicity, income, education and marital status. Studies were largely from North America, Europe and China, limiting the diversity of included populations and variance in social determinants. Interpretation: Findings show that machine learning models, as well as SDoH and related variables, improve CVD prediction model performance. The limited variety of sources and data in studies emphasize that there is opportunity to include more SDoH variables, especially environmental ones, that are known CVD risk factors in machine learning CVD prediction models. Given their flexibility, ML may provide opportunity to incorporate and model the complex nature of social determinants. Such data should be recorded in electronic databases to enable their use.


2021 ◽  
Vol 40 ◽  
pp. 03007
Author(s):  
Ruby Hasan

In the last few years, cardiovascular diseases have emerged as one of the most common causes of deaths worldwide. The lifestyle changes, eating habits, working cultures etc, has significantly contributed to this alarming issue across the globe including the developed, underdeveloped and developing nations. Early detection of the initial signs of cardiovascular diseases and the continuous medical supervision can help in reducing rising number of patients and eventually the mortality rate. However with limited medical facilities and specialist doctors, it is difficult to continuously monitor the patients and provide consultations. Technological interventions are required to facilitate the patient monitoring and treatment. The healthcare data generated through various medical procedures and continuous patient monitoring can be utilized to develop efficient prediction models for cardiovascular diseases. The early prognosis of cardiovascular illnesses can aid in making decisions on life-style changes in high hazard sufferers and in turn lessen the complications, which may be an outstanding milestone inside the field of medicine. This paper studies some of the most widely used machine learning algorithms for heart disease prediction by using the medical data and historical information. The various techniques are discussed and a comparative analysis of the same is presented. This report compares five common strategies for predicting the chance of heart attack that have been published in the literature. KNN, Decision Tree, Gaussian Naive Bayes, Logistic Regression, and Random Forest are some of the approaches used. Further, the paper also highlights the advantages and disadvantages of using the various techniques for developing the prediction models.


Author(s):  
Anantvir Singh Romana

Accurate diagnostic detection of the disease in a patient is critical and may alter the subsequent treatment and increase the chances of survival rate. Machine learning techniques have been instrumental in disease detection and are currently being used in various classification problems due to their accurate prediction performance. Various techniques may provide different desired accuracies and it is therefore imperative to use the most suitable method which provides the best desired results. This research seeks to provide comparative analysis of Support Vector Machine, Naïve bayes, J48 Decision Tree and neural network classifiers breast cancer and diabetes datsets.


2018 ◽  
Author(s):  
Liyan Pan ◽  
Guangjian Liu ◽  
Xiaojian Mao ◽  
Huixian Li ◽  
Jiexin Zhang ◽  
...  

BACKGROUND Central precocious puberty (CPP) in girls seriously affects their physical and mental development in childhood. The method of diagnosis—gonadotropin-releasing hormone (GnRH)–stimulation test or GnRH analogue (GnRHa)–stimulation test—is expensive and makes patients uncomfortable due to the need for repeated blood sampling. OBJECTIVE We aimed to combine multiple CPP–related features and construct machine learning models to predict response to the GnRHa-stimulation test. METHODS In this retrospective study, we analyzed clinical and laboratory data of 1757 girls who underwent a GnRHa test in order to develop XGBoost and random forest classifiers for prediction of response to the GnRHa test. The local interpretable model-agnostic explanations (LIME) algorithm was used with the black-box classifiers to increase their interpretability. We measured sensitivity, specificity, and area under receiver operating characteristic (AUC) of the models. RESULTS Both the XGBoost and random forest models achieved good performance in distinguishing between positive and negative responses, with the AUC ranging from 0.88 to 0.90, sensitivity ranging from 77.91% to 77.94%, and specificity ranging from 84.32% to 87.66%. Basal serum luteinizing hormone, follicle-stimulating hormone, and insulin-like growth factor-I levels were found to be the three most important factors. In the interpretable models of LIME, the abovementioned variables made high contributions to the prediction probability. CONCLUSIONS The prediction models we developed can help diagnose CPP and may be used as a prescreening tool before the GnRHa-stimulation test.


Author(s):  
Cheng-Chien Lai ◽  
Wei-Hsin Huang ◽  
Betty Chia-Chen Chang ◽  
Lee-Ching Hwang

Predictors for success in smoking cessation have been studied, but a prediction model capable of providing a success rate for each patient attempting to quit smoking is still lacking. The aim of this study is to develop prediction models using machine learning algorithms to predict the outcome of smoking cessation. Data was acquired from patients underwent smoking cessation program at one medical center in Northern Taiwan. A total of 4875 enrollments fulfilled our inclusion criteria. Models with artificial neural network (ANN), support vector machine (SVM), random forest (RF), logistic regression (LoR), k-nearest neighbor (KNN), classification and regression tree (CART), and naïve Bayes (NB) were trained to predict the final smoking status of the patients in a six-month period. Sensitivity, specificity, accuracy, and area under receiver operating characteristic (ROC) curve (AUC or ROC value) were used to determine the performance of the models. We adopted the ANN model which reached a slightly better performance, with a sensitivity of 0.704, a specificity of 0.567, an accuracy of 0.640, and an ROC value of 0.660 (95% confidence interval (CI): 0.617–0.702) for prediction in smoking cessation outcome. A predictive model for smoking cessation was constructed. The model could aid in providing the predicted success rate for all smokers. It also had the potential to achieve personalized and precision medicine for treatment of smoking cessation.


2020 ◽  
Vol 8 (Suppl 3) ◽  
pp. A62-A62
Author(s):  
Dattatreya Mellacheruvu ◽  
Rachel Pyke ◽  
Charles Abbott ◽  
Nick Phillips ◽  
Sejal Desai ◽  
...  

BackgroundAccurately identified neoantigens can be effective therapeutic agents in both adjuvant and neoadjuvant settings. A key challenge for neoantigen discovery has been the availability of accurate prediction models for MHC peptide presentation. We have shown previously that our proprietary model based on (i) large-scale, in-house mono-allelic data, (ii) custom features that model antigen processing, and (iii) advanced machine learning algorithms has strong performance. We have extended upon our work by systematically integrating large quantities of high-quality, publicly available data, implementing new modelling algorithms, and rigorously testing our models. These extensions lead to substantial improvements in performance and generalizability. Our algorithm, named Systematic HLA Epitope Ranking Pan Algorithm (SHERPA™), is integrated into the ImmunoID NeXT Platform®, our immuno-genomics and transcriptomics platform specifically designed to enable the development of immunotherapies.MethodsIn-house immunopeptidomic data was generated using stably transfected HLA-null K562 cells lines that express a single HLA allele of interest, followed by immunoprecipitation using W6/32 antibody and LC-MS/MS. Public immunopeptidomics data was downloaded from repositories such as MassIVE and processed uniformly using in-house pipelines to generate peptide lists filtered at 1% false discovery rate. Other metrics (features) were either extracted from source data or generated internally by re-processing samples utilizing the ImmunoID NeXT Platform.ResultsWe have generated large-scale and high-quality immunopeptidomics data by using approximately 60 mono-allelic cell lines that unambiguously assign peptides to their presenting alleles to create our primary models. Briefly, our primary ‘binding’ algorithm models MHC-peptide binding using peptide and binding pockets while our primary ‘presentation’ model uses additional features to model antigen processing and presentation. Both primary models have significantly higher precision across all recall values in multiple test data sets, including mono-allelic cell lines and multi-allelic tissue samples. To further improve the performance of our model, we expanded the diversity of our training set using high-quality, publicly available mono-allelic immunopeptidomics data. Furthermore, multi-allelic data was integrated by resolving peptide-to-allele mappings using our primary models. We then trained a new model using the expanded training data and a new composite machine learning architecture. The resulting secondary model further improves performance and generalizability across several tissue samples.ConclusionsImproving technologies for neoantigen discovery is critical for many therapeutic applications, including personalized neoantigen vaccines, and neoantigen-based biomarkers for immunotherapies. Our new and improved algorithm (SHERPA) has significantly higher performance compared to a state-of-the-art public algorithm and furthers this objective.


Author(s):  
Wan Adlina Husna Wan Azizan ◽  
A'zraa Afhzan Ab Rahim ◽  
Siti Lailatul Mohd Hassan ◽  
Ili Shairah Abdul Halim ◽  
Noor Ezan Abdullah

Sign in / Sign up

Export Citation Format

Share Document